Professional Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-100
Closed -$7K 120
2022
Q3
$7K Hold
100
﹤0.01% 318
2022
Q2
$8K Hold
100
﹤0.01% 313
2022
Q1
$7K Hold
100
﹤0.01% 346
2021
Q4
$6K Hold
100
﹤0.01% 355
2021
Q3
$6K Hold
100
﹤0.01% 301
2021
Q2
$7K Hold
100
﹤0.01% 296
2021
Q1
$6K Hold
100
﹤0.01% 274
2020
Q4
$6K Buy
+100
New +$6.15K ﹤0.01% 274

Other funds holding BMY

Professional Financial Advisors's BMY Position: Q4 2022 in Review

Professional Financial Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 100 shares — an estimated $7K sold.

Professional Financial Advisors first reported a position in BMY in Q4 2020 and held it in 8 quarters. The position peaked at $8K in Q2 2022. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

  • Professional Financial Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
  • Professional Financial Advisors sold 100 Bristol-Myers Squibb shares in Q4 2022, an estimated $7K.
  • Professional Financial Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 8 quarters.
  • Professional Financial Advisors's Bristol-Myers Squibb position peaked at $8K in Q2 2022.
  • 2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Professional Financial Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.